• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日间治疗与精神药物在精神分裂症患者后续护理中的应用。一项退伍军人管理局合作研究。

Day treatment and psychotropic drugs in the aftercare of schizophrenic patients. A Veterans Administration cooperative study.

作者信息

Linn M W, Caffey E M, Klett C J, Hogarty G E, Lamb H R

出版信息

Arch Gen Psychiatry. 1979 Sep;36(10):1055-66. doi: 10.1001/archpsyc.1979.01780100025002.

DOI:10.1001/archpsyc.1979.01780100025002
PMID:224831
Abstract

Schizophrenic patients referred for day treatment at the time of discharge from ten hospitals were randomly assigned to receive day treatment plus drugs or to receive drugs alone. They were tested before assignment and at 6, 12, 18, and 24 months on social functioning, symptoms, and attitudes. Community tenure and costs were also measured. The ten day centers were described on process variables every six months for the four years of the study. Some centers were found to be effective in treating chronic schizophrenic patients and others were not. All centers improved the patients' social functioning. Six of the centers were found to significantly delay relapse, reduce sumptoms, and change some attitudes. Costs for patients in these centers were not significantly different from the group receiving only drugs. More professional staff hours, group therapy, and a high patient turnover treatment philosophy were associated with poor-result centers. More occupational therapy and a sustained nonthreatening environment were more characteristic of successful outcome centers.

摘要

从十家医院出院时被转介接受日间治疗的精神分裂症患者被随机分配,一组接受日间治疗加药物治疗,另一组仅接受药物治疗。在分配前以及在6个月、12个月、18个月和24个月时,对他们进行社会功能、症状和态度方面的测试。还对社区居住时间和费用进行了测量。在为期四年的研究中,每六个月对十个日间治疗中心的过程变量进行描述。发现一些中心在治疗慢性精神分裂症患者方面有效,而其他中心则不然。所有中心都改善了患者的社会功能。发现其中六个中心能显著延迟复发、减轻症状并改变一些态度。这些中心患者的费用与仅接受药物治疗的组没有显著差异。专业工作人员工作时长更多、采用团体治疗以及高患者周转率的治疗理念与效果不佳的中心相关。更多的职业治疗和持续的无威胁环境更具成功治疗结果中心的特征。

相似文献

1
Day treatment and psychotropic drugs in the aftercare of schizophrenic patients. A Veterans Administration cooperative study.日间治疗与精神药物在精神分裂症患者后续护理中的应用。一项退伍军人管理局合作研究。
Arch Gen Psychiatry. 1979 Sep;36(10):1055-66. doi: 10.1001/archpsyc.1979.01780100025002.
2
Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates.
Arch Gen Psychiatry. 1974 Nov;31(5):603-8. doi: 10.1001/archpsyc.1974.01760170005001.
3
Resocialization of schizophrenic patients.精神分裂症患者的再社会化
Am J Occup Ther. 1975 May-Jun;29(5):288-90.
4
Therapeutic modality comparisons in day treatment.日间治疗中的治疗方式比较
Am J Occup Ther. 1986 Sep;40(9):606-11. doi: 10.5014/ajot.40.9.606.
5
Intensive treatment of the chronic schizophrenic.慢性精神分裂症的强化治疗
Psychiatr Q. 1967 Jul;41(3):550-6. doi: 10.1007/BF01562616.
6
Drug and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of nonrelapsed patients.
Arch Gen Psychiatry. 1974 Nov;31(5):609-18. doi: 10.1001/archpsyc.1974.01760170011002.
7
Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.氯氮平治疗难治性精神分裂症成本效益研究中的多重结果评估。退伍军人事务部氯氮平治疗难治性精神分裂症合作研究小组。
Health Serv Res. 1998 Dec;33(5 Pt 1):1237-61.
8
Low serum neuroleptic levels predict relapse in schizophrenic patients.血清中抗精神病药物水平低预示着精神分裂症患者会复发。
Arch Gen Psychiatry. 1982 Sep;39(9):998-1000. doi: 10.1001/archpsyc.1982.04290090008002.
9
Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates.精神分裂症患者后续护理中的药物治疗与社会心理治疗。一年复发率。
Arch Gen Psychiatry. 1973 Jan;28(1):54-64. doi: 10.1001/archpsyc.1973.01750310038007.
10
Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. II. Two-year effects of a controlled study on relapse and adjustment. Environmental-Personal Indicators in the Course of Schizophrenia (EPICS) Research Group.家庭心理教育、社交技能训练及维持化疗在精神分裂症后续治疗中的应用。II. 一项关于复发与适应的对照研究的两年效果。精神分裂症病程中的环境-个人指标(EPICS)研究小组。
Arch Gen Psychiatry. 1991 Apr;48(4):340-7. doi: 10.1001/archpsyc.1991.01810280056008.

引用本文的文献

1
Day hospital versus admission for acute psychiatric disorders.日间医院治疗与急性精神障碍住院治疗的比较
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD004026. doi: 10.1002/14651858.CD004026.pub2.
2
Schizophrenia and Psychoeducation: Model for intervention in family practice.精神分裂症与心理教育:家庭实践中的干预模式。
Can Fam Physician. 1991 Nov;37:2457-65.
3
Day hospital versus outpatient care for people with schizophrenia.精神分裂症患者的日间医院护理与门诊护理对比
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD003240. doi: 10.1002/14651858.CD003240.pub2.
4
Thioridazine for schizophrenia.用于治疗精神分裂症的硫利达嗪。
Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD001944. doi: 10.1002/14651858.CD001944.pub2.
5
Day centres for severe mental illness.严重精神疾病日间护理中心。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD001710. doi: 10.1002/14651858.CD001710.pub2.
6
Use of nationwide outcomes monitoring data to compare clinical outcomes in specialized mental health programs and general psychiatric clinics in the Veterans Health Administration.利用全国性结果监测数据比较退伍军人健康管理局中专业心理健康项目和普通精神科诊所的临床结果。
Psychiatr Q. 2006 Summer;77(2):151-72. doi: 10.1007/s11126-006-9004-0.
7
Measuring the costs of schizophrenia. Implications for the post-institutional era in the US.衡量精神分裂症的成本。对美国后机构时代的影响。
Pharmacoeconomics. 1995 Sep;8(3):199-222. doi: 10.2165/00019053-199508030-00004.
8
Development of clinical methods for utilization review in psychiatric day treatment.
J Ment Health Adm. 1994 Summer;21(3):298-312. doi: 10.1007/BF02521336.
9
Mental health care costs: paucity of measurement.精神卫生保健成本:测量方法的匮乏。
Soc Psychiatry Psychiatr Epidemiol. 1996 Mar;31(2):70-7. doi: 10.1007/BF00801902.
10
A special population. The elderly deinstitutionalized chronically mentally ill patient.
Psychiatr Q. 1983 Summer-Fall;55(2-3):90-105. doi: 10.1007/BF01064845.